MBIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MBIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Mustang Bio's Revenue per Share for the three months ended in Dec. 2024 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
For the Biotechnology subindustry, Mustang Bio's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Mustang Bio's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Mustang Bio's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Mustang Bio (NAS:MBIO) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Thank you for viewing the detailed overview of Mustang Bio's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Fortress Biotech, Inc. | 10 percent owner | 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS FL 33154 |
Rosenwald Lindsay A Md | director | 375 PARK AVE, NEW YORK NY 10152 |
Manuel Md Litchman | director, officer: President and CEO | 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK NY 10017 |
Eliot M Lurier | officer: Interim CFO | C/O TENAX THERAPEUTICS, INC., ONE COPLEY PARKWAY, SUITE 490, MORRISVILLE NC 27560 |
Brian Achenbach | officer: SVP, Fin. & Corp. Controller | 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK NY 10014 |
Neil Herskowitz | director | 2109 BROADWAY, SUITE 206, NEW YORK NY 10023 |
Adam J. Chill | director | 24 NEW ENGLAND EXECUTIVE PARK, SUITE 105, BURLINGTON MA 01803 |
Michael S Weiss | director | 750 LEXINGTON AVE, NEW YORK NY 10022 |
Michael J Zelefsky | director | |
David J Horin | officer: Interim CFO | 1270 AVENUE OF THE AMERICAS, 16TH FLOOR, NEW YORK NY 10020 |
From GuruFocus
By GuruFocus Research • 02-07-2024
By Marketwired • 07-06-2023
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By Marketwired • 01-14-2025
By Marketwired • 08-03-2023
By GuruFocus Research • 02-07-2024
By Marketwired • 02-06-2025
By Marketwired • 04-30-2024
By GuruFocus Research • 02-07-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.